share_log

Returns On Capital Are Showing Encouraging Signs At Insulet (NASDAQ:PODD)

Returns On Capital Are Showing Encouraging Signs At Insulet (NASDAQ:PODD)

Insulet(納斯達克股票代碼:PODD)的資本回報率顯示出令人鼓舞的跡象
Simply Wall St ·  05/22 21:46

What are the early trends we should look for to identify a stock that could multiply in value over the long term? Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and secondly, an increasing amount of capital employed. Put simply, these types of businesses are compounding machines, meaning they are continually reinvesting their earnings at ever-higher rates of return. So when we looked at Insulet (NASDAQ:PODD) and its trend of ROCE, we really liked what we saw.

我們應該看什麼早期趨勢來判斷一隻長期能夠翻倍的股票呢?業務應該會呈現兩個趨勢,首先是資本僱用率增長;這體現了企業以越來越高的回報率將利潤再投資於業務。因此,納斯達克g-iii服裝集團的資本僱用率回報率(ROCE)目前看起來不錯,讓我們看看回報率的趨勢能告訴我們什麼。資產回報率:它是什麼?資本使用率回報(ROCE)是什麼?ROCE 趨勢可以告訴我們什麼?比起 Enphase Energy,有更好的資本回報率選擇。在過去的五年中,該公司增加了 1,306% 的資本,而該資本的回報率保持穩定在 9.9%。這樣差的回報率現在並不令人信服,而且隨着資本的增加,很明顯企業並沒有將資金投入到高回報的投資中。資本利用率。簡單來說,這些類型的企業是複利機器,意味着它們不斷地以越來越高的回報率再投資收益。所以當我們看着銀休特(NASDAQ:PODD)以及它的資本回報率趨勢時,我們真的很喜歡我們看到的。

What Is Return On Capital Employed (ROCE)?

我們對 Enphase Energy 的資本僱用回報率的看法:正如我們上面看到的,Enphase Energy 的資本回報率沒有提高,但它正在重新投資於業務。投資者必須認爲未來會有更好的前景,因爲股票表現良好,使持股五年以上的股東獲得了 690% 的收益。最終,如果基本趨勢持續存在,我們不會對它成爲一隻多頭股持有期很久很有信心。

Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. The formula for this calculation on Insulet is:

如果您不確定的話,ROCE是評估公司在其業務中投資的資本賺取多少稅前收入的指標(以百分比形式)。這個計算公式在銀休特上的結果是:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

資產僱用回報率(ROCE)是指企業利潤,即企業稅前利潤除以企業投入的總資本(負債加股權)。如果ROCE高於企業財務成本的承受能力,那麼企業就會創造出更多的價值。

0.12 = US$265m ÷ (US$2.6b - US$432m) (Based on the trailing twelve months to March 2024).

0.12 = 2.65億美元 ÷ (26億美元 - 4.32億美元)在Elevance Health上,我們已經注意到的趨勢是相當令人放心的。數據顯示,過去五年資產回報率大幅提高至15%。投資所用資產的規模也增加了30%。這表明有很多機會進行內部資本投資,並以更高的速度不斷增長,這種組合在多倍增長方面很常見。.

Thus, Insulet has an ROCE of 12%. In absolute terms, that's a pretty normal return, and it's somewhat close to the Medical Equipment industry average of 10%.

因此,銀休特的ROCE爲12%。絕對上看,這是一個相當正常的回報,且與醫療設備行業平均水平的10%趨近。

roce
NasdaqGS:PODD Return on Capital Employed May 22nd 2024
NasdaqGS:PODD資本利用率回報2024年5月22日

Above you can see how the current ROCE for Insulet compares to its prior returns on capital, but there's only so much you can tell from the past. If you'd like, you can check out the forecasts from the analysts covering Insulet for free.

您可以看到銀休特當前ROCE與其過去的資本回報率相比如何,但從過去中可以得到的信息是有限的。如果您願意,您可以免費查看覆蓋銀休特的分析師對其的預測。

The Trend Of ROCE

當尋找下一個倍增器時,如果您不確定從哪裏開始,請關注幾個關鍵趨勢。首先,我們希望看到一個經過驗證的資本使用率。如果您看到這一點,通常意味着這是一家擁有出色業務模式和大量盈利再投資機會的公司。然而,調查蒙托克可再生能源公司(NASDAQ:MNTK)後,我們認爲它的現行趨勢不符合倍增器的模式。

The trends we've noticed at Insulet are quite reassuring. The data shows that returns on capital have increased substantially over the last five years to 12%. Basically the business is earning more per dollar of capital invested and in addition to that, 161% more capital is being employed now too. The increasing returns on a growing amount of capital is common amongst multi-baggers and that's why we're impressed.

我們注意到銀休特的趨勢相當令人放心。數據顯示,在過去五年中,資本回報率大幅提高至12%。基本上,企業每投資一美元就能賺取更多收益,此外,現在使用的資本也增加了161%。在不斷增長的資本中實現回報率增加是許多成功企業共有的特點,這也是我們印象深刻的原因。

What We Can Learn From Insulet's ROCE

銀休特ROCE的啓示

All in all, it's terrific to see that Insulet is reaping the rewards from prior investments and is growing its capital base. And with a respectable 67% awarded to those who held the stock over the last five years, you could argue that these developments are starting to get the attention they deserve. So given the stock has proven it has promising trends, it's worth researching the company further to see if these trends are likely to persist.

總的來說,看到銀休特從之前的投資中獲得了回報並增加了資本基礎是非常棒的。並且,在過去五年中持有該股票的投資者獲得了67%的尊重,這說明這些發展正開始受到關注。所以,考慮到該股票已經證明了它具有有前途的趨勢,值得進一步研究該公司以確定這些趨勢是否會持續。

One more thing to note, we've identified 1 warning sign with Insulet and understanding it should be part of your investment process.

還有一件事需要注意,我們已經確定銀休特存在1個警告信號,在您的投資過程中,了解它應該是必不可少的。

While Insulet may not currently earn the highest returns, we've compiled a list of companies that currently earn more than 25% return on equity. Check out this free list here.

儘管銀休特目前的回報率不是最高的,但我們已經編制了比目前股權回報率高於25%的公司列表。點擊此處查看這份免費名單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論